Integra LifeSciences (IART) to Release Earnings on Monday

Integra LifeSciences (NASDAQ:IART) will be announcing its earnings results before the market opens on Monday, November 4th. Analysts expect the company to announce earnings of $0.39 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Integra LifeSciences Stock Up 2.8 %

Shares of IART opened at $19.28 on Friday. The firm has a market capitalization of $1.50 billion, a price-to-earnings ratio of 66.48, a PEG ratio of 0.66 and a beta of 1.09. Integra LifeSciences has a 52 week low of $16.81 and a 52 week high of $45.42. The company has a debt-to-equity ratio of 1.17, a quick ratio of 2.10 and a current ratio of 3.39. The business’s fifty day moving average price is $18.62 and its two-hundred day moving average price is $24.57.

Wall Street Analysts Forecast Growth

IART has been the subject of a number of research reports. Bank of America lowered their price objective on Integra LifeSciences from $26.00 to $18.00 and set an “underperform” rating for the company in a research report on Monday, October 7th. Morgan Stanley boosted their price target on shares of Integra LifeSciences from $24.00 to $27.00 and gave the stock an “underweight” rating in a research note on Monday, July 15th. BTIG Research raised shares of Integra LifeSciences from a “sell” rating to a “neutral” rating in a report on Monday, October 7th. Citigroup cut their price target on Integra LifeSciences from $20.00 to $16.00 and set a “sell” rating on the stock in a research note on Tuesday, October 1st. Finally, JMP Securities decreased their price objective on Integra LifeSciences from $40.00 to $35.00 and set a “market outperform” rating for the company in a research note on Tuesday, July 30th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $26.50.

Integra LifeSciences Company Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.